Skip to main navigation
Skip to search
Skip to main content
Mayo Clinic Home
Home
Profiles
Departments/Divisions
Grants
Research output
Prizes
Search by expertise, name or affiliation
Gefitinib: A new agent in palliative care
Eric Prommer
Hematology/Oncology
Research output
:
Contribution to journal
›
Review article
›
peer-review
4
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Gefitinib: A new agent in palliative care'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Gefitinib
100%
Palliative Care
76%
Lung Neoplasms
25%
United States Food and Drug Administration
15%
Tablets
14%
Opioid Analgesics
14%
Oxygen
11%
Radiotherapy
11%
Neoplasms
10%
Physicians
10%